Mabpharm Ltd
HKEX:2181
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mabpharm Ltd
HKEX:2181
|
CN |
|
O
|
Origin Enterprises PLC
ISEQ:OIZ
|
IE |
|
Titan International Inc
NYSE:TWI
|
US |
|
S
|
Siav SpA
MIL:SIAV
|
IT |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
|
Woodward Inc
NASDAQ:WWD
|
US |
|
M
|
MTN Group Ltd
JSE:MTN
|
ZA |
|
Drilling Tools International Corp
NASDAQ:DTI
|
US |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
Windsor Machines Ltd
NSE:WINDMACHIN
|
IN |
|
Viq Solutions Inc
TSX:VQS
|
CA |
|
Cipher Mining Inc
NASDAQ:CIFR
|
US |
|
H
|
Heineken Holding NV
OTC:HKHHF
|
NL |
|
F
|
FKS Food Sejahtera Tbk PT
IDX:AISA
|
ID |
Bankruptcy Probability
Mabpharm Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mabpharm Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
M
|
Mabpharm Ltd
HKEX:2181
|
2.3B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mabpharm Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mabpharm Ltd has total debt of 194.9m CNY. This includes both short-term (0 CNY) and long-term (194.9m CNY) debt.
You can find a full breakdown on its Balance Sheet.
